US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that may mimic GLP-1 drugs for years after ...
Under the agreement, participating states will receive “discounts and rebates” from the drugmakers if the treatments don’t ...
Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunru crafted a bespoke treatment that has successfully corrected the genetic defect.
Monash University researchers, in collaboration with Harvard University, have discovered how to permanently "switch off" ...
Eli Lilly is continuing a run of dealmaking to strengthen its genetic medicine offering by penning a pact with gene editing ...
Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...
Scientists have achieved a genetic feat once thought impossible: removing an entire extra human chromosome using gene-editing ...
The gene therapy cell culture media market in North America, Europe, and Asia-Pacific is poised for growth due to rising clinical trials, increased biomanufacturing, and demand for GMP-compliant media ...
Explore groundbreaking gene-editing therapy for kidney disease, offering hope to those with polycystic kidney disease.
Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results